Royal Philips NV Sponsored ADR Stock News

For any countries that have yet to agree a deal, new tariff rates are due to come into effect on Friday, Aug. 1—though such deadlines have proved to be flexible in the past.

Koninklijke Philips N.V. (NYSE:PHG ) Q2 2025 Earnings Conference Call July 29, 2025 3:00 AM ET Company Participants Charlotte Hanneman - Executive VP, CFO & Member of Board of Management Durga Doraisamy - Corporate Participant Roy Jakobs - President, CEO & Chairman of the Board of Management Conference Call Participants David James Adlington - JPMorgan Chase & Co, Research Division Edward Nicho...

Shares of health device maker Phillips rallied as much as 14% on Tuesday as the company lifted its earnings guidance despite a hefty hit from tariffs.

July 29, 2025 Long-term multiyear agreements will see Philips installing its advanced Azurion image-guided therapy systems nationwide across all provinces, including rural and remote areas Initiative brings minimally invasive care to millions of cardiac, stroke and cancer patients in Indonesia Combines cutting-edge treatment technology, services and training to strengthen Indonesia's health inf...

Dutch healthcare technology company Philips said it expects an impact of 150-200 million euros ($173-232 million) from import tariffs after the U.S. and the European Union agreedto the United States imposing a 15% rate on most EU goods.

July 29, 2025 Q2 2025 Group Highlights Comparable order intake growth 6% Group sales EUR 4.3 billion, reflecting 1% increase in comparable sales Income from operations EUR 400 million Adjusted EBITA margin increased 130 bps to 12.4% of sales Free cash flow increased to EUR 230 million Philips increases full year 2025 outlook for Adjusted EBITA margin and free cash flow; reiterates comparable sa...

July 24, 2025 Philips will now offer the largest cardiac care portfolio through Epic's Aura platform CAMBRIDGE, Mass. – Royal Philips (NYSE: PHG, AEX: PHIA) a global leader in health technology, today announced a collaboration with Epic to integrate Philips' suite of cardiac ambulatory monitoring and diagnostics services with Aura, the specialty diagnostics suite of the leading electronic healt...

July 23, 2025 Supporting prostate cancer diagnosis with more precise guidance for clinicians, offering better patient care Amsterdam, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, today announced a major advancement in image-guided navigation for prostate cancer care with the FDA 510(k) clearance of the latest Philips UroNav version. The system in...